Home/ Stocks/ GLMD

Galmed Pharmaceuticals Ltd.

GLMD XNAS

$0.59 +0.01 (+1.29%) ▲ 15-min delayed

Open

$0.58

High

$0.59

Low

$0.57

Volume

21.0K

Market Cap

$3.82M

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Employees: 6 Website →

Earnings & Analyst Ratings

Next Earnings: Wed, May 20, 2026

Calendar →

Related Market News

No specific coverage for GLMD yet. Check out our latest market news or earnings calendar.

Get GLMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Galmed Pharmaceuticals Ltd..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.